Article

Drug repurposing and polypharmacology to fight SARS-CoV-2 through inhibition of the main…

Research square · 2020 · Luca Pinzi, author Annachiara Tinivella, author Fabiana Caporuscio, author Giulio Rastelli, author

Key facts

Title Drug repurposing and polypharmacology to fight SARS-CoV-2 through inhibition of the main protease
First author Luca Pinzi, author Annachiara Tinivella, author Fabiana Caporuscio, author Giulio Rastelli, author
Journal Research square
Published Dec 3, 2020
DOI 10.21203/rs.3.rs-27222/v2
Devices mentioned K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature